Pricing Log in Create free account

PROCEPT BioRobotics Corporation (PRCT) vs Tandem Diabetes Care, Inc. (TNDM)

PROCEPT BioRobotics Corporation and Tandem Diabetes Care, Inc. are both Medical Devices companies. Tandem Diabetes Care, Inc. is the larger, with a market value of $1.2B against $1.0B — 1.1× the size. PROCEPT BioRobotics Corporation grew revenue faster over the last twelve months: 22.7% against 3.96%. Tandem Diabetes Care, Inc. has the higher net margin (−6.08% vs −32.5%) and the higher return on invested capital (−10.3% vs −43.6%). Across the 18 metrics below, PROCEPT BioRobotics Corporation leads on 9 and Tandem Diabetes Care, Inc. on 9.

Valuation

Metric PRCT TNDM Medical Devices median
P/E n/m n/m 23.22
P/S 2.97 1.07 2.34
P/B 2.95 8.56 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales 2.46 1.21 2.24
Earnings yield (11.04%) (5.75%) (10.09%)
Free cash flow yield (8.47%) (8.59%) (8.47%)

Profitability

Metric PRCT TNDM Medical Devices median
Gross margin 64.22% 56.01% 56.01%
Operating margin (33.86%) (4.40%) (15.03%)
Net margin (32.54%) (6.08%) (20.40%)
Free cash flow margin (25.17%) (2.56%) (7.24%)
Return on equity (30.24%) (48.03%) (15.32%)
Return on assets (22.12%) (6.24%) (19.72%)
Return on invested capital (43.57%) (10.33%) (10.33%)

Growth

Metric PRCT TNDM Medical Devices median
Revenue growth (TTM) 22.69% 3.96% 8.80%
EPS growth (last fiscal year) 1.71% (106.80%) 29.03%
Revenue growth, 5-year CAGR 109.04% 15.26% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PRCT TNDM Medical Devices median
Debt to equity 0.15 4.62 0.07
Current ratio 6.55 3.18 2.50
Net debt to EBITDA 2.41 (0.10) 0.49

Dividend

Metric PRCT TNDM Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric PRCT TNDM Medical Devices median
Market cap 1.04b 1.15b 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack